← All trials
NCT06721689
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2025
- Primary completion
- Apr 30, 2030
- Completion date
- Apr 30, 2031
- First posted
- Dec 6, 2024
- Last posted
- Dec 6, 2024
- Enrollment
- 59
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PennsylvaniaLead sponsor
- University of PennsylvaniaSponsor investigator
- Peel Therapeutics IncCollaborator
- University of PennsylvaniaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.